D-1094-2017 Class III Terminated

Recalled by AVKARE Inc. — Pulaski, TN

FDA drug recall D-1094-2017 was initiated by AVKARE Inc. on Jul 19, 2017 and is designated Class III. Reason for recall: Failed impurities/degradation specifications: Out of specification for a related compound C. The recall status is terminated (terminated Mar 11, 2019). Affected quantity: 1172 cartons (23440 tablets).

Recall details

Product Type
Drugs
Report Date
Aug 23, 2017
Initiation Date
Jul 19, 2017
Termination Date
Mar 11, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1172 cartons (23440 tablets)

Product description

Voriconazole Tablets, 200 mg, 20-count cartons (4 x 5) Unit Dose, Rx only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 50268-804-12

Reason for recall

Failed impurities/degradation specifications: Out of specification for a related compound C.

Distribution pattern

Nationwide

Code information

Lot #: 16933, Exp 07/2018; 17054, Exp 08/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1094-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1094-2017. Report a data issue: hello@regdatalab.com.